| News
Basel startup Nutrix beats 900 startups
11.11.2019
The Basel startup Nutrix has won a competition at the Web Summit with its business concept. It has developed a nanosensor that measures glucose levels in users’ saliva to prevent diabetes. Nutrix is supported by the Venture Mentoring program of BaselArea.swiss and has been shortlisted for the DayOne Accelerator.
Maria Hahn, Founder of Nutrix, on Center Stage of Web Summit 2019
According to an article at startupticker.ch, the Web Summit, one of the largest annual conferences for the global technology industry, took place in the first week of November. During the conference a competition for start-ups was also held, enabling them to present their business concept. This year, around 900 startups took part, and the winner was the Basel-based Medtech startup Nutrix.
It has developed a nanosensor that is placed on the tooth to measure glucose levels in users’ saliva and transfers information to an external app. At the same time, the sensor tracks food intake and provides dietary tips on this basis, allowing it to be used to prevent diabetes. Co-founder Maria Hahn underlined during the presentation that preventative measures such as these could shape the future of medicine.
Hahn and the second co-founder Nikjil Singh first developed their idea together in spring this year. They are already working towards building a prototype. Nutrix has close links with Basel Children’s Hospital (UKBB).
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Ricola earns the trust of Switzerland
Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.
Read More
docdok.health involved in coronavirus research project
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.
Read More
Celonic agrees cooperation to combat coronavirus
The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.
Read More
Idorsia receives payment of 45 million US dollars
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..
Read More
Humard robot disinfects using UV light
Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.
Read More
Roche authorized to distribute coronavirus antibody tests
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.
Read More
Basel is the most popular Swiss location for headquarters
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.
Read More
Healthtech sector growing rapidly in the Basel Area
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.
Read More
Support program has roots in Basel
The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.
Read More
University Hospital Basel treats coronavirus patients with plasma
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.
Read More
